Approvals/CIMA-AEMPS/GANCICLOVIR HIKMA 500 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG

Approved

STANDARD

GANCICLOVIR HIKMA 500 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e4d266c6ab7ebcba
Drug Cima Aemps Name: GANCICLOVIR HIKMA 500 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Register Number: 89450
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2024-03-21
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

GANCICLOVIR SODICO

543 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 21, 2024

Approval ID

e4d266c6ab7ebcba

Type

Standard